Terms: = Endocrine gland cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6
54 results:
1. Modulatory effect of pomegranate peel extract on key regulators of ovarian cellular processes
Kolesarova A; Baldovska S; Kohut L; Vasicek J; Ivanisova E; Arvay J; Duracka M; Roychoudhury S
Front Endocrinol (Lausanne); 2023; 14():1277155. PubMed ID: 38027211
[TBL] [Abstract] [Full Text] [Related]
2. Dysregulation of the circ_0087502/miR-1179/tgfbr2 pathway supports gemcitabine resistance in pancreatic cancer.
Chen M; Liu X; Lu J; Teng H; Yu C; Liu Y; Zheng Y
Cancer Biol Ther; 2023 Dec; 24(1):2258566. PubMed ID: 37844011
[TBL] [Abstract] [Full Text] [Related]
3. Unraveling the Roles of miR-204-5p and HMGA2 in Papillary Thyroid cancer Tumorigenesis.
Van Branteghem C; Augenlicht A; Demetter P; Craciun L; Maenhaut C
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445942
[TBL] [Abstract] [Full Text] [Related]
4. USP33 promotes pancreatic cancer malignant phenotype through the regulation of tgfbr2/TGFβ signaling pathway.
Liu X; Xu J; Shen B; Xu J; Jiang J
Cell Death Dis; 2023 Jun; 14(6):362. PubMed ID: 37322017
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
Liu X; Zhang C; Wang X; Cui C; Cui H; Zhu B; Chen A; Zhang L; Xin J; Fu Q; Dionigi G; Sun H
Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36606578
[TBL] [Abstract] [Full Text] [Related]
6. Common Key Genes in Differentiating Parathyroid Adenoma From Thyroid Adenoma.
Lin Y; He J; Mou Z; Tian Y; Chen H; Guan T; Chen L
Horm Metab Res; 2023 Mar; 55(3):212-221. PubMed ID: 36599456
[TBL] [Abstract] [Full Text] [Related]
7. Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study.
de Castro Silva I; Bianchi A; Deshpande NU; Sharma P; Mehra S; Garrido VT; Saigh SJ; England J; Hosein PJ; Kwon D; Merchant NB; Datta J
Elife; 2022 Sep; 11():. PubMed ID: 36107485
[TBL] [Abstract] [Full Text] [Related]
8. CRISPR-mediated tgfbr2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling.
Fix SM; Forget MA; Sakellariou-Thompson D; Wang Y; Griffiths TM; Lee M; Haymaker CL; Dominguez AL; Basar R; Reyes C; Kumar S; Meyer LA; Hwu P; Bernatchez C; Jazaeri AA
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35882447
[TBL] [Abstract] [Full Text] [Related]
9. The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification.
Yang Y; Ding Y; Gong Y; Zhao S; Li M; Li X; Song G; Zhai B; Liu J; Shao Y; Zhu L; Pang J; Ma Y; Ou Q; Wu X; Zhang Z
BMC Cancer; 2022 Feb; 22(1):186. PubMed ID: 35180847
[TBL] [Abstract] [Full Text] [Related]
10. Targeting Tumor-Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic cancer.
Dosch AR; Singh S; Dai X; Mehra S; Silva IC; Bianchi A; Srinivasan S; Gao Z; Ban Y; Chen X; Banerjee S; Nagathihalli NS; Datta J; Merchant NB
Mol Cancer Ther; 2021 Nov; 20(11):2280-2290. PubMed ID: 34518296
[TBL] [Abstract] [Full Text] [Related]
11. Predictors of malignancy in incidental adnexal lesions identified on CT in patients with prior non-ovarian cancer.
Shinagare AB; Gujrathi I; Cochon L; Burk KS; Sadowski E; Khorasani R
Abdom Radiol (NY); 2022 Jan; 47(1):320-327. PubMed ID: 34468797
[TBL] [Abstract] [Full Text] [Related]
12. Combined Blockade of MEK and CDK4/6 Pathways Induces Senescence to Improve Survival in Pancreatic Ductal Adenocarcinoma.
Willobee BA; Gaidarski AA; Dosch AR; Castellanos JA; Dai X; Mehra S; Messaggio F; Srinivasan S; VanSaun MN; Nagathihalli NS; Merchant NB
Mol Cancer Ther; 2021 Jul; 20(7):1246-1256. PubMed ID: 34001634
[TBL] [Abstract] [Full Text] [Related]
13. Clinical utility of
Peres KC; Teodoro L; Amaral LHP; Teixeira ES; Barreto IS; de Freitas LLL; Maximo V; Assumpção LVM; Bufalo NE; Ward LS
Arch Endocrinol Metab; 2021 Nov; 65(2):172-184. PubMed ID: 33905626
[TBL] [Abstract] [Full Text] [Related]
14. Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
Sano M; Takahashi R; Ijichi H; Ishigaki K; Yamada T; Miyabayashi K; Kimura G; Mizuno S; Kato H; Fujiwara H; Nakatsuka T; Tanaka Y; Kim J; Masugi Y; Morishita Y; Tanaka M; Ushiku T; Nakai Y; Tateishi K; Ishii Y; Isayama H; Moses HL; Koike K
Gut; 2021 Sep; 70(9):1713-1723. PubMed ID: 33087490
[TBL] [Abstract] [Full Text] [Related]
15. Genomic characterization of malignant progression in neoplastic pancreatic cysts.
Noë M; Niknafs N; Fischer CG; Hackeng WM; Beleva Guthrie V; Hosoda W; Debeljak M; Papp E; Adleff V; White JR; Luchini C; Pea A; Scarpa A; Butturini G; Zamboni G; Castelli P; Hong SM; Yachida S; Hiraoka N; Gill AJ; Samra JS; Offerhaus GJA; Hoorens A; Verheij J; Jansen C; Adsay NV; Jiang W; Winter J; Albores-Saavedra J; Terris B; Thompson ED; Roberts NJ; Hruban RH; Karchin R; Scharpf RB; Brosens LAA; Velculescu VE; Wood LD
Nat Commun; 2020 Aug; 11(1):4085. PubMed ID: 32796935
[TBL] [Abstract] [Full Text] [Related]
16. Pattern of Invasion in Human Pancreatic cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome.
Huang W; Navarro-Serer B; Jeong YJ; Chianchiano P; Xia L; Luchini C; Veronese N; Dowiak C; Ng T; Trujillo MA; Huang B; Pflüger MJ; Macgregor-Das AM; Lionheart G; Jones D; Fujikura K; Nguyen-Ngoc KV; Neumann NM; Groot VP; Hasanain A; van Oosten AF; Fischer SE; Gallinger S; Singhi AD; Zureikat AH; Brand RE; Gaida MM; Heinrich S; Burkhart RA; He J; Wolfgang CL; Goggins MG; Thompson ED; Roberts NJ; Ewald AJ; Wood LD
Cancer Res; 2020 Jul; 80(13):2804-2817. PubMed ID: 32376602
[TBL] [Abstract] [Full Text] [Related]
17. Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic cancer.
Dosch AR; Dai X; Reyzer ML; Mehra S; Srinivasan S; Willobee BA; Kwon D; Kashikar N; Caprioli R; Merchant NB; Nagathihalli NS
Mol Cancer Res; 2020 Apr; 18(4):623-631. PubMed ID: 31949002
[TBL] [Abstract] [Full Text] [Related]
18. Ganglioside GM2, highly expressed in the MIA PaCa-2 pancreatic ductal adenocarcinoma cell line, is correlated with growth, invasion, and advanced stage.
Sasaki N; Hirabayashi K; Michishita M; Takahashi K; Hasegawa F; Gomi F; Itakura Y; Nakamura N; Toyoda M; Ishiwata T
Sci Rep; 2019 Dec; 9(1):19369. PubMed ID: 31852956
[TBL] [Abstract] [Full Text] [Related]
19. A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of tgfbr2.
Zhu X; Zhang T; Zhang Y; Chen H; Shen J; Jin X; Wei J; Zhang E; Xiao M; Fan Y; Mao R; Zhou G
Cell Signal; 2020 Feb; 66():109470. PubMed ID: 31730895
[TBL] [Abstract] [Full Text] [Related]
20. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.
Matsuura T; Maru Y; Izumiya M; Hoshi D; Kato S; Ochiai M; Hori M; Yamamoto S; Tatsuno K; Imai T; Aburatani H; Nakajima A; Hippo Y
Carcinogenesis; 2020 Jun; 41(4):490-501. PubMed ID: 31233118
[TBL] [Abstract] [Full Text] [Related]
[Next]
